United States · FDA National Drug Code directory
Carbidopa, Levodopa, and Entacapone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0781-5669_2176ea25-da6b-47b2-a081-b3da614df0a0
- Product NDC
- 0781-5669
- Form
- TABLET, FILM COATED
- Composition / generic term
- Carbidopa, Levodopa, and Entacapone
- Labeler
- Sandoz Inc
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 20140618
- Source listing expiry
- 20271231
Source-listed ingredients
- CARBIDOPA — 50 mg/1
- LEVODOPA — 200 mg/1
- ENTACAPONE — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED in 1 BOTTLE (0781-5669-01) · 0781-5669-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →